An AED Unlike Any Other: The First and Only FDA-Approved Cannabidiol

This presentation will help with a greater understanding of the clinical signs & symptoms, diagnosis, and treatment of seizures associated with seizure disorders of Dravet Syndrome, Tuberous Sclerosis Complex, and Lennox-Gastaut Syndrome. Understanding FDA vs. Non-FDA approved Cannabinoid. Review of FDA-approved medication Epidiolex, Phase 3 Trails, side-effects, drug-to-drug interactions, administration, monitoring.

Nanette Wrobel, RPh

Nanette is a pharmacist educator who for 40 years has done training, education and speaking for physicians, nurses and other health professionals. She focuses on clinical health and medication education in the area of intellectual and developmental disabilities. Medication management, drug safety, treatment assessments, new drugs on the market and disease states are some of the many topics she has discussed for organizations all over the country.

She has produced a national newsletter reaching thousands of health professionals and is widely sought after to present health education webinars on a variety of subjects impacting those individuals with intellectual and developmental disabilities. She is one of the clinical resources for a national pharmacy, Tarrytown Expocare, specializing in providing medications and medication management to facilities across the United States who care for individuals with I/DD.